skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 382  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove subject: Tumors remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential
Material Type:
Article
Add to My Research

A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential

BMC cancer, 2019-06, Vol.19 (1), p.581-581, Article 581 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5768-0 ;PMID: 31200666

Full text available

2
Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Material Type:
Article
Add to My Research

Clinical effects of curcumin in enhancing cancer therapy: A systematic review

BMC cancer, 2020-08, Vol.20 (1), p.791-11, Article 791 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07256-8 ;PMID: 32838749

Full text available

3
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Material Type:
Article
Add to My Research

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC cancer, 2017-05, Vol.17 (1), p.332-332, Article 332 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3286-5 ;PMID: 28511673

Full text available

4
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
Material Type:
Article
Add to My Research

Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice

BMC cancer, 2019-02, Vol.19 (1), p.151-151, Article 151 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5354-5 ;PMID: 30764783

Full text available

5
A convolutional neural network-based system to classify patients using FDG PET/CT examinations
Material Type:
Article
Add to My Research

A convolutional neural network-based system to classify patients using FDG PET/CT examinations

BMC cancer, 2020-03, Vol.20 (1), p.227-227, Article 227 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-6694-x ;PMID: 32183748

Full text available

6
A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01
Material Type:
Article
Add to My Research

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

BMC cancer, 2019-12, Vol.19 (1), p.1250-1250, Article 1250 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6442-2 ;PMID: 31881853

Full text available

7
Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma
Material Type:
Article
Add to My Research

Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma

BMC cancer, 2021-07, Vol.21 (1), p.1-876, Article 876 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08550-9 ;PMID: 34332578

Full text available

8
Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality
Material Type:
Article
Add to My Research

Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality

BMC cancer, 2019-04, Vol.19 (1), p.334-334, Article 334 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5543-2 ;PMID: 30961556

Full text available

9
Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis
Material Type:
Article
Add to My Research

Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis

BMC cancer, 2020-11, Vol.20 (1), p.1150-1150, Article 1150 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07654-y ;PMID: 33238978

Full text available

10
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review
Material Type:
Article
Add to My Research

Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review

BMC cancer, 2020-06, Vol.20 (1), p.507-507, Article 507 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06948-5 ;PMID: 32493233

Full text available

11
A specific gene expression signature for visceral organ metastasis in breast cancer
Material Type:
Article
Add to My Research

A specific gene expression signature for visceral organ metastasis in breast cancer

BMC cancer, 2019-04, Vol.19 (1), p.333-333, Article 333 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5554-z ;PMID: 30961553

Full text available

12
Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study
Material Type:
Article
Add to My Research

Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study

BMC cancer, 2019-02, Vol.19 (1), p.139-139, Article 139 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5344-7 ;PMID: 30744596

Full text available

13
Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis
Material Type:
Article
Add to My Research

Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis

BMC cancer, 2021-06, Vol.21 (1), p.1-697, Article 697 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08358-7 ;PMID: 34126961

Full text available

14
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer
Material Type:
Article
Add to My Research

A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer

BMC cancer, 2021-11, Vol.21 (1), p.1221-1221, Article 1221 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08975-2 ;PMID: 34774009

Full text available

15
Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection
Material Type:
Article
Add to My Research

Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection

BMC cancer, 2022-06, Vol.22 (1), p.1-664, Article 664 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09743-6 ;PMID: 35715783

Full text available

16
INHBA is a prognostic predictor for patients with colon adenocarcinoma
Material Type:
Article
Add to My Research

INHBA is a prognostic predictor for patients with colon adenocarcinoma

BMC cancer, 2020-04, Vol.20 (1), p.305-305, Article 305 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06743-2 ;PMID: 32293338

Full text available

17
Advances in personalized radiotherapy
Material Type:
Article
Add to My Research

Advances in personalized radiotherapy

BMC cancer, 2024-05, Vol.24 (1), p.556-556 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12317-3 ;PMID: 38702617

Full text available

18
A gene expression-based study on immune cell subtypes and glioma prognosis
Material Type:
Article
Add to My Research

A gene expression-based study on immune cell subtypes and glioma prognosis

BMC cancer, 2019-11, Vol.19 (1), p.1116-1116, Article 1116 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6324-7 ;PMID: 31729963

Full text available

19
Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma
Material Type:
Article
Add to My Research

Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma

BMC cancer, 2022-08, Vol.22 (1), p.1-872, Article 872 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09967-6 ;PMID: 35945526

Full text available

20
Classification prediction of pancreatic cystic neoplasms based on radiomics deep learning models
Material Type:
Article
Add to My Research

Classification prediction of pancreatic cystic neoplasms based on radiomics deep learning models

BMC cancer, 2022-11, Vol.22 (1), p.1237-1237, Article 1237 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10273-4 ;PMID: 36447168

Full text available

Results 1 - 20 of 382  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait